• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Alexion product sales trend

anonymous

Guest
Sales trend of Soliris, Strensiq and Kanuma. Hope you find it useful -- More

Alexion-Pharmaceuticals-Product-Sales-Trend.png